Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kenvue is a leading global consumer health company that transitioned from being the Consumer Health division of Johnson & Johnson to an independent public entity in 2023. The company manages a diverse portfolio of iconic brands including Tylenol, Motrin, Zyrtec, Neutrogena, Aveeno, and Listerine. Its business is organized into three primary segments: Self Care, Skin Health and Beauty, and Essential Health. Kenvue leverages a legacy of scientific innovation to provide over-the-counter medicines and personal care products that address everyday health needs for consumers worldwide. Headquartered in New Jersey, the company operates globally with a focus on science-backed health and wellness solutions. As the world's largest pure-play consumer health company by revenue, it maintains a significant presence in the pain, allergy, and specialized skincare markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Johnson & Johnson Consumer.